Rebalix
UBS · sheet of 9 September 2026
UBS · sheet of 9 September 2026ETF sheet · official issuer and register data
UBS Core S&P 500 UCITS ETF hGBP dis
IE00BD34DL14 · IE00BD34DL14 · GBP · domicile Ireland
EquityGBP-hedged share classSFDR art. 6
Index tracked: S&P 500 Total Return Net (hedged to GBP)
- TER
- 0.06%+ trans. 0.00%
- Fund size
- —
- Tracking difference
- +0.10%3-year avg
- 🇮🇹 tax rate
- 26.00%white list 0.00%
- Replication
- Physical
- Income
- Distributingsemi-annual
Launch 2 Nov 2016 · costs from the KID as of 26 Aug 2026 · 1 venues (ESMA register)
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 2 Sept 2026
Il Fondo è a gestione passiva e mira a replicare la performance dell'indice S&P 500 hedged to GBP Index (Net Return) (l'«Indice»).
L'Indice è concepito per misurare la performance delle 500 maggiori società quotate sui mercati degli Stati Uniti.
Il Fondo cercherà di detenere tutte le azioni dell'Indice nella medesima percentuale, in modo tale che il portafoglio del Fondo sarà sostanzialmente un'immagine quasi speculare dell'Indice. Nel cercare di realizzare il suo obiettivo d'investimento di replicare l'andamento dell'Indice, in circostanze…
Performance since series start (in euro) — base 100
2 Nov 2016 → 4 Sept 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
Returns in euro
| 1 year | +21.6% |
| 3 years | +72.9% |
| 5 years | +70.5% |
| 10 years | series too young |
| Since series start | +281.0% |
Risk · 1 / 3 / 5 years
| Volatility (ann.) | 12.84% | 14.95% | 17.14% |
| Max drawdown | −9.58% | −18.83% | −26.84% |
| Sharpe | 1.20 | 1.05 | 0.51 |
| Sortino | 1.73 | 1.53 | 0.73 |
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · IE00BD34DL14 · IE00BD34DL141
RebalixIE00BD34DL14 · IE00BD34DL14 · sheet of 9 September 2026
Tracking difference — year by year
Fund minus index, complete calendar years · fund with dividends reinvested by Rebalix on each ex-date (no issuer total-return series); index from the declared series
| Year | Fund | Index | TD |
|---|---|---|---|
| 2025 | +17.71% | +17.56% | +0.15% |
| 2024 | +24.15% | +24.04% | +0.11% |
| 2023 | +23.71% | +23.66% | +0.05% |
| 2022 | −20.35% | −20.34% | −0.01% |
| 2021 | +27.62% | +27.65% | −0.03% |
Distributions · per share, in GBP
Frequency: semi-annual · last 12 months: 0.3503 GBP (0.92% of NAV) · last ex-date 13 Aug 2026
| Year | Payments | Total (GBP) | Dividend yield |
|---|---|---|---|
| 2026 | 2 | 0.3503 | — |
| 2025 | 2 | 0.3117 | +1.07% |
| 2024 | 2 | 0.2695 | +1.13% |
| 2023 | 2 | 0.2458 | +1.26% |
| 2022 | 2 | 0.2459 | +1.00% |
Dividend yield: the year’s distributions over the share value (NAV) at the start of the year.
Listing venues
ESMA register (FIRDS) and official exchange lists
BCF8 · Tradegate Exchange
+ 3 unmapped venues (MTF, RFQ, professional)
Official documents
Clickable links in the PDF
The live sheet, always up to date
rebalix.com/en/etf/IE00BD34DL14
Series, distributions, holdings and documents refresh daily.
rebalix.com/en/etf/IE00BD34DL14
Series, distributions, holdings and documents refresh daily.
Sheet produced on 9 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.
Rebalix · IE00BD34DL14 · IE00BD34DL142